The observation that Cdk2 inhibitor SNS-032 selectively induces apoptosis in ovarian cancer cells with elevated CCNE1 expression prompted us to investigate its efficacy to suppress ovarian tumor progression with the well-established ovarian tumor peritoneal metastatic colonization model [20, 21]. Here, CCNE1 is linked to ovarian cancer.